Respiratory syncytial virus (RSV) is a contagious respiratory infection and a leading cause of illness in children. This activity includes five conversations with experts in nursing, pediatrics, and neonatology. They review RSV basics, current immunoprophylaxis options, and tools to help clinicians prevent RSV in infants and young children, with detailed discussion of RSV antibodies, supporting evidence, and recommendations.
Improving Knowledge and Awareness of Preventive Antibodies for RSV Infants and Young Children
Claim This Podcastby Annenberg Center for Health Sciences
5.0(1 reviews)
5 episodes
Updated Daily
Accepts GuestsHas Sponsors
Podcast Overview
Respiratory syncytial virus (RSV) is a contagious respiratory infection and a leading cause of illness in children. This activity includes five conversations with experts in nursing, pediatrics, and neonatology. They review RSV basics, current immunoprophylaxis options, and tools to help clinicians prevent RSV in infants and young children, with detailed discussion of RSV antibodies, supporting evidence, and recommendations.
Language
🇺🇲
Publishing Since
2/13/2026
1 verified contact email on file for Improving Knowledge and Awareness of Preventive Antibodies for RSV Infants and Young Children
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
February 13, 2026
Tools to Facilitate RSV Prevention
<ul><li>Resources for Clinicians</li><li>Practical Considerations</li></ul>
February 13, 2026
Clinical Recommendations for RSV Prevention
<ul><ul><li>Organizational Guidance</li><li>Infants <8 Months</li><li>Infants/Young Children 8-19 Months</li><li>Antibody Administration</li></ul></ul>
February 13, 2026
RSV Immunoprophylaxis Strategies in Infants/Young Children
<ul><li>Historical Use of Palivizumab</li><li>Basics of RSV Antibodies</li><li>Nirsevimab</li><li>Clesrovimab</li></ul>
5 total episodes available
Deep-dive analytics for Improving Knowledge and Awareness of Preventive Antibodies for RSV Infants and Young Children
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Improving Knowledge and Awareness of Preventive Antibodies for RSV Infants and Young Children?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.